Eukaryotic DNA repair is blocked at different steps by inhibitors of DNA topoisomerases and of DNA polymerases alpha and beta.
D002460:Cell Line; D003110:Colonic Neoplasms; D003561:Cytarabine / Q000494:pharmacology; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors*; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors*; D004260:DNA Repair; D015224:Dideoxynucleosides; D006801:Humans; D007700:Kinetics; D009268:Nalidixic Acid / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D019384:Nucleic Acid Synthesis Inhibitors; D013936:Thymidine / Q000031:analogs & derivatives / Q000494:pharmacology; D059004:Topoisomerase I Inhibitors
D015224:Dideoxynucleosides; D019384:Nucleic Acid Synthesis Inhibitors; D059004:Topoisomerase I Inhibitors; D003561:Cytarabine; D009675:Novobiocin; C019336:2',3'-dideoxythymidine; D009268:Nalidixic Acid; D004256:DNA Polymerase I; D004257:DNA Polymerase II; D013936:Thymidine